Most people who have been following the stock market over the past year know the name Cathie Wood. The founder of asset management firm ARK Invest has parlayed her strategy of investing in cutting-edge technology companies, and her notable media appearances, into a place as one of the most closely followed money managers today. She's earned the attention: All of ARK's funds have more than doubled their investors' money in the past year.
Despite her overall successes, though, her funds do hold a few stocks that have fallen out of favor with Wall Street. CRISPR Therapeutics (NASDAQ: CRSP) and Proto Labs (NYSE: PRLB) are down significantly from their recent highs. For investors looking to profit from either the gene-editing or additive manufacturing revolutions, those slumps could spell opportunity. And those who purchase either stock can feel secure in the knowledge that one of the world's hottest investors has done so too.
Image source: Getty Images.
For further details see:
2 Cathie Wood Stocks That Are 40% Off